- Journal of Lipid and Atherosclerosis Update 2025
-
Heo JH, Jeong IK
- KMID: 2565038
- J Lipid Atheroscler.
- 2025 Jan;14(1):3-4.
- doi: 10.12997/jla.2025.14.1.3
-
- CITED
-
- Close
- SHARE
-
- Close
- Journal of Lipid and Atherosclerosis in 2025: From Excellence to Eminence
-
Jeong IK
- KMID: 2565036
- J Lipid Atheroscler.
- 2025 Jan;14(1):1-2.
- doi: 10.12997/jla.2025.14.1.1
-
- CITED
-
- Close
- SHARE
-
- Close
- Chylomicron Characteristics Are Associated With Microsomal Triglyceride Transfer Protein in an Animal Model of Diet-Induced Dysbiosis
-
Olano C, Fariña G, Wiszniewski M, Medel J, Morales C, Friedman S, Macri V, Barchuk M, Berg G, Schreier L, Zago V
- KMID: 2565031
- J Lipid Atheroscler.
- 2025 Jan;14(1):106-119.
- doi: 10.12997/jla.2025.14.1.106
Objective: Intestinal remnant chylomicrons (CMs) are involved in cardiovascular residual risk and the atherogenic process. Microsomal triglyceride transfer protein (MTTP) catalyzes the assembly of lipids to apolipoprotein B48, generating CMs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
-
Bril F, Berg G, Barchuk M, Nogueira JP
- KMID: 2565041
- J Lipid Atheroscler.
- 2025 Jan;14(1):5-29.
- doi: 10.12997/jla.2025.14.1.5
Dyslipidemia is a major risk factor for cardiovascular disease, and its impact may be exacerbated when accompanied by metabolic dysfunction-associated steatotic liver disease (MASLD). The simultaneous management of these conditions... -
- CITED
-
- Close
- SHARE
-
- Close
- Response to Letter Regarding Article, Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?
-
Sharma JB, Patel R
- KMID: 2565034
- J Lipid Atheroscler.
- 2025 Jan;14(1):130-131.
- doi: 10.12997/jla.2025.14.1.130
-
- CITED
-
- Close
- SHARE
-
- Close
- Corrigendum to Previously Published Articles
-
- KMID: 2565035
- J Lipid Atheroscler.
- 2025 Jan;14(1):132-133.
- doi: 10.12997/jla.2025.14.1.132
-
- CITED
-
- Close
- SHARE
-
- Close
- Letter by Isa Ardahanli Regarding Article, Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?
-
Ardahanli I, Ozmen M
- KMID: 2565033
- J Lipid Atheroscler.
- 2025 Jan;14(1):128-129.
- doi: 10.12997/jla.2025.14.1.128
-
- CITED
-
- Close
- SHARE
-
- Close
- Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
-
Tada H, Kojima N, Yamagami K, Takeji Y, Sakata K, Usui S, Kawashiri Ma, Takamura M
- KMID: 2565032
- J Lipid Atheroscler.
- 2025 Jan;14(1):120-127.
- doi: 10.12997/jla.2025.14.1.120
Objective: Lipoprotein (a) (Lp[a]), which is a highly heritable trait, is associated with coronary artery disease (CAD). However, the insight into whether the association between Lp(a) and CAD differs according... -
- CITED
-
- Close
- SHARE
-
- Close
- Application of Generative Artificial Intelligence in Dyslipidemia Care
-
Ahn J, Kim B
- KMID: 2565042
- J Lipid Atheroscler.
- 2025 Jan;14(1):77-93.
- doi: 10.12997/jla.2025.14.1.77
Dyslipidemia dramatically increases the risk of cardiovascular diseases, necessitating appropriate treatment techniques. Generative AI (GenAI), an advanced AI technology that can generate diverse content by learning from vast datasets, provides... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Pathways in Diabetic Cardiomyopathy and the Role of Antihyperglycemic Drugs Beyond Their Glucose Lowering Effect
-
Lee JE, Kim BG, Won JC
- KMID: 2565040
- J Lipid Atheroscler.
- 2025 Jan;14(1):54-76.
- doi: 10.12997/jla.2025.14.1.54
Epidemiological evidence has shown that diabetes is associated with overt heart failure (HF) and worse clinical outcomes. However, the presence of a distinct primary diabetic cardiomyopathy (DCM) has not been... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardioprotective Effects of Adiponectin-Stimulated Autophagy
-
Tam E, Ouimet M, Sweeney G
- KMID: 2565039
- J Lipid Atheroscler.
- 2025 Jan;14(1):40-53.
- doi: 10.12997/jla.2025.14.1.40
Cardiovascular diseases (CVDs), including heart failure, pose a significant economic and health burden worldwide. Current treatment strategies for heart failure are greatly limited, in that they mainly mitigate symptoms or... -
- CITED
-
- Close
- SHARE
-
- Close
- Discrepant Effect of High-Density Lipoprotein Cholesterol on the Hematologic Malignancy Risk: A Nationwide Cohort Study
-
Nam SY, Jo J, Lee WK
- KMID: 2565043
- J Lipid Atheroscler.
- 2025 Jan;14(1):94-105.
- doi: 10.12997/jla.2025.14.1.94
Objective: Although high-density lipoprotein cholesterol (HDL-C) is inversely associated with hematologic malignancies, modification by smoking has not been reported. We investigated how smoking and menopausal status modify these association. Methods: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Atherosclerotic Cardiovascular Disease in Cancer Survivors: Current Evidence, Risk Prediction, Prevention, and Management
-
Choi A, Kim S, Kim S, Cho I, Cha MJ, You SC
- KMID: 2565037
- J Lipid Atheroscler.
- 2025 Jan;14(1):30-39.
- doi: 10.12997/jla.2025.14.1.30
While advances in cancer treatment have led to improved survival rates, cancer survivors are at a significant risk of developing atherosclerotic cardiovascular disease (ASCVD). This review examines the risk, diagnosis, and... -
- CITED
-
- Close
- SHARE
-
- Close
